-The Hindu There are recognised ways to overcome the patents hurdle, ensuring social justice and boosting the COVID-19 battle In order to achieve global herd immunity and prevent new strains of COVID-19 from emerging, possibly for years to come, vaccines need to be affordable and available in massive quantities throughout the globe. This can happen through patent owners voluntarily licensing their products to other companies, especially Indian producers who are experienced at...

-The Indian Express The United States will pursue negotiations at WTO to waive intellectual property for Covid-19 vaccines. This can allow large-scale production in middle-income countries, but there are arguments against the move. The United States on Wednesday announced support for waiving intellectual property protection for Covid-19 vaccines, saying extraordinary circumstances call for extraordinary measures. United States Trade Representative Katherine Tai said the US will pursue “text-based negotiations” on the waiver at...

-Hindustan Times A rapid and universal vaccination programme is essential to control a surge of this magnitude and time is of the essence — for the virus is not standing still The second wave of Covid-19 is overwhelming India. The official death toll is already inching towards 250,000, but this is almost surely a vast underestimate, as the virus sweeps through rural India and kills many whose deaths will never be captured...

-The Financial Express The 12th Ministerial Conference must deliver a permanent solution on public stockholding for ensuring food security of millions reeling under Covid-induced poverty The work for the 12th Ministerial Conference (MC 12) of the World Trade Organization (WTO) —to be held in Geneva, from November 30 to December 3—that had been delayed by the Covid-19 pandemic has gained momentum since the joining of the new director general of the WTO,...

-The Hindu Over the last few decades, intellectual property rules have served as a lethal barrier to the right to access healthcare Even an unprecedented pandemic can do little, it appears, to upset the existing global regime governing monopoly rights over the production and distribution of life-saving drugs. If anything, since the onset of COVID-19, we’ve only seen a reaffirmation of intellectual property rules that have served as a lethal barrier to...